Management tracks

Array BioPharma Inc. (NASDAQ:ARRY) promoted Andrew Robbins to COO from SVP of commercial operations. Robbins will succeed David Snitman, who will serve as EVP of business development until he retires in June.

NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) named Jeff Jonker as president and David Woodhouse as CFO. Jonker was SVP of corporate and business development at Theravance Biopharma Inc. (NASDAQ:TBPH) and Theravance Inc. (NASDAQ:THRX). Woodhouse was managing director and co-head of U.S. biotechnology investment banking at Goldman Sachs. ...